ARCHIVES

Study Tests PARP Inhibitor ABT-888 For Several Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

High Cervical Cancer Rates Indicate Access Problems

August 26, 2005

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002